Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- PMID: 33176080
- PMCID: PMC7673303
- DOI: 10.1056/NEJMc2031364
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Figures
Similar articles
-
Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient.Infect Dis Now. 2021 Oct;51(7):633-635. doi: 10.1016/j.idnow.2021.01.010. Epub 2021 Jan 27. Infect Dis Now. 2021. PMID: 33527098 Free PMC article. No abstract available.
-
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.J Infect Chemother. 2021 Feb;27(2):387-389. doi: 10.1016/j.jiac.2020.12.001. Epub 2020 Dec 4. J Infect Chemother. 2021. PMID: 33328135 Free PMC article.
-
Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19.Ann Am Thorac Soc. 2021 May;18(5):900-903. doi: 10.1513/AnnalsATS.202008-931RL. Ann Am Thorac Soc. 2021. PMID: 33119425 Free PMC article. No abstract available.
-
Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature.Australas J Dermatol. 2021 Feb;62(1):e98-e101. doi: 10.1111/ajd.13442. Epub 2020 Sep 13. Australas J Dermatol. 2021. PMID: 32920868 Review.
-
Dritte Covid-Impfung für Immunsupprimierte.MMW Fortschr Med. 2021 Dec;163(21-22):36-37. doi: 10.1007/s15006-021-0633-x. MMW Fortschr Med. 2021. PMID: 34888793 Free PMC article. Review. German. No abstract available.
Cited by
-
Longitudinal Analyses after COVID-19 Recovery or Prolonged Infection Reveal Unique Immunological Signatures after Repeated Vaccinations.Vaccines (Basel). 2022 Oct 28;10(11):1815. doi: 10.3390/vaccines10111815. Vaccines (Basel). 2022. PMID: 36366324 Free PMC article.
-
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.Cell Rep Med. 2021 Apr 20;2(4):100255. doi: 10.1016/j.xcrm.2021.100255. Epub 2021 Apr 5. Cell Rep Med. 2021. PMID: 33842902 Free PMC article.
-
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.Nat Microbiol. 2022 Nov;7(11):1906-1917. doi: 10.1038/s41564-022-01254-1. Epub 2022 Oct 26. Nat Microbiol. 2022. PMID: 36289399 Free PMC article. Clinical Trial.
-
Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.Viruses. 2021 May 21;13(6):953. doi: 10.3390/v13060953. Viruses. 2021. PMID: 34064066 Free PMC article.
-
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections.Front Immunol. 2022 Sep 13;13:984784. doi: 10.3389/fimmu.2022.984784. eCollection 2022. Front Immunol. 2022. PMID: 36177014 Free PMC article.
References
-
- Deane KD, West SG. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 2005;35:154-165. - PubMed
-
- Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465-469. - PubMed
-
- He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020;26:672-675. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous